NERVGEN PHARMA CORP. (NGEN)
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
NervGen Pharma Corp. Common stock
NASDAQ:NGENHealthcare · Biotechnology
-4.86%$1.37
AH$1.44+5.11%vs close
Mkt Cap$147.43M
Float80.61M
O/S107.62M
Vol
$ Vol
RVOL
Inst Own11.2%
SI6.3%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$31.58M
Total Assets$16.62M
Free Cash Flow-$13.96M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$6K
Total Equity$2.49M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in NGEN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$16.62M
Liabilities$14.13M
Accounts Receivable$58K
Accounts Payable$3.33M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$293K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $60K | $104K | $82K | $31K | $28K | $28K | $14K | $0 |
| Gross Profit | $0 | -$60K | -$104K | -$82K | -$31K | -$28K | -$28K | -$14K | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - |
| Research and Development | $9.96M | $11.21M | $5.73M | $11.76M | $4.93M | $4.39M | $4.74M | $557K | $0 |
| Selling, General, and Administrative | $8M | $6.57M | $6.9M | $4.5M | $4.28M | $3.61M | $2.48M | $398K | $9K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $17.95M | $17.78M | $12.62M | $16.26M | $9.21M | $8M | $7.23M | $955K | $9K |
| Operating Income (EBIT) | -$17.95M | -$17.84M | -$12.73M | -$16.34M | -$9.24M | -$8.03M | -$7.25M | -$969K | -$9K |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $365K | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $239K | $581K | $394K | $143K | $21K | $14K | $73K | $0 | $0 |
| Other Income (Expense) | -$13.63M | $663K | -$3.3M | $1.63M | $61K | $7K | $73K | $0 | $0 |
| Income Before Tax (EBT) | -$31.58M | -$17.17M | -$16.02M | -$14.7M | -$9.18M | -$8.03M | -$7.18M | -$969K | -$9K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$31.58M | -$17.17M | -$16.02M | -$14.7M | -$9.18M | -$8.03M | -$7.18M | -$969K | -$9K |
| Net Income Margin | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||
| EPS | -0.61 | -0.36 | -0.37 | -0.39 | -0.33 | -0.34 | -0.39 | -0.05 | 0.00 |
| Diluted EPS | -0.61 | -0.36 | -0.37 | -0.39 | -0.33 | -0.34 | -0.39 | -0.05 | 0.00 |
| Weighted Average OS | 72.33M | 67.32M | 59.29M | 52.65M | 39.29M | 32.11M | 25.90M | 27.20M | 27.20M |
| EBITDA | -$4.05M | -$17.11M | -$15.92M | -$14.26M | -$9.15M | -$8M | -$7.15M | -$955K | -$9K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $15.8M | $12.35M | $8.35M | $15.93M | $12.21M | $4.02M | $3.02M | $1.77M |
| Short-Term Investments | $0 | $70K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $15.8M | $12.42M | $8.35M | $15.93M | $12.21M | $4.02M | $3.02M | $1.77M |
| Accounts Receivable | $58K | $297K | $179K | $19K | $46K | $45K | $90K | $18K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $6K | $727K | $278K | $376K | $224K | $327K | $0 | $35K |
| Total Current Assets | $16.32M | $13.6M | $8.96M | $16.43M | $12.57M | $4.45M | $4.6M | $1.82M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $0 | $0 | $143K | $210K | $2K | $1K | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $293K | $333K | $373K | $306K | $341K | $338K | $375K | $391K |
| Long-Term Investments | $0 | $6K | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $293K | $339K | $516K | $516K | $343K | $340K | $375K | $391K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $16.62M | $13.94M | $9.48M | $16.94M | $12.91M | $4.79M | $4.98M | $2.21M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $3.33M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $70K | $66K | $61K | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $10.79M | $11.19M | $10.46M | $6.83M | $778K | $542K | $679K | $320K |
| Total Current Liabilities | $14.13M | $12.09M | $10.84M | $7.25M | $778K | $542K | $679K | $320K |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $96K |
| Total Long-Term Liabilities | $0 | $6K | $76K | $140K | $0 | $0 | $0 | $96K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $14.13M | $12.1M | $10.91M | $7.39M | $778K | $542K | $679K | $416K |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $73.73M | $58.02M | $42.19M | $40.74M | $30.59M | $16.46M | $11.25M | $2.74M |
| Retained Earnings | -$105.06M | -$73.08M | -$55.95M | -$39.57M | -$25.28M | -$16.02M | -$8.19M | -$978K |
| Comprehensive Income & Other | $0 | $16.91M | $12.32M | $8.39M | $6.83M | $3.8M | $1.24M | $27K |
| Other Stockholders' Equity | $33.82M | $16.91M | $12.32M | $8.39M | $6.83M | $3.8M | $1.24M | $27K |
| Total Equity | $2.49M | $1.84M | -$1.44M | $9.55M | $12.13M | $4.25M | $4.3M | $1.79M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $16.62M | $13.94M | $9.48M | $16.94M | $12.91M | $4.79M | $4.98M | $2.21M |
| Supplementary Data | ||||||||
| Total Debt | $6K | $76K | $141K | $201K | $0 | $0 | $0 | $0 |
| Net Debt | -$15.79M | -$12.28M | -$8.21M | -$15.73M | -$12.21M | -$4.02M | -$3.02M | -$1.77M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$31.58M | -$17.17M | -$16.02M | -$14.7M | -$9.18M | -$8.03M | -$7.18M | -$969K |
| Depreciation & Amortization | $40K | $60K | $104K | $82K | $31K | $28K | $28K | $14K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $3.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $239K | -$118K | -$160K | $26K | -$1K | $43K | -$71K | -$18K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$192K | $0 | $0 | $0 | $0 | $0 | $0 | $195K |
| Other Working Capital | $423K | $718K | -$12K | $1.47M | $312K | $967K | $223K | $41K |
| Total Working Capital Change | $471K | $600K | -$172K | $1.5M | $311K | $1.01M | $152K | $217K |
| Other Non-Cash Items | $13.25M | $4.47M | $8.01M | $502K | $2.87M | $2.46M | $1.05M | -$4K |
| Net Cash from Operating | -$13.96M | -$12.05M | -$8.09M | -$12.62M | -$5.96M | -$4.53M | -$5.95M | -$742K |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | -$101K | -$15K | -$33K | -$2K | $0 | -$90K |
| Acquisitions | $0 | $0 | $2K | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $42K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $72K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $72K | $42K | -$99K | -$15K | -$33K | -$2K | $0 | -$90K |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $17.72M | $16.31M | $621K | $16.12M | $14.15M | $5.63M | $7.24M | $2.56M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$639K | -$72K | -$72K | -$54K | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $17.01M | $16.24M | $549K | $16.07M | $14.15M | $5.63M | $7.24M | $2.56M |
| Forex Effect | $312K | -$934K | $269K | -$374K | $52K | $18K | $9K | $36K |
| Net Change in Cash | $3.44M | $3.3M | -$7.37M | $3.06M | $8.2M | $1.12M | $1.29M | $1.77M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$13.96M | -$12.05M | -$8.09M | -$12.62M | -$5.96M | -$4.53M | -$5.95M | -$742K |
| Capital Expenditure | $0 | $0 | -$4K | -$15K | -$2K | -$2K | $0 | $0 |
| Free Cash Flow | -$13.96M | -$12.05M | -$8.09M | -$12.63M | -$5.97M | -$4.53M | -$5.95M | -$742K |
| Cash at Beginning | $12.36M | $9.06M | $15.72M | $12.87M | $4.01M | $2.89M | $1.73M | $0 |
| Cash at End | $15.8M | $12.35M | $8.35M | $15.93M | $12.21M | $4.02M | $3.02M | $1.77M |